Status:
RECRUITING
Addressing Genomic Disparities in Cancer Survivors
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
Georgetown University
National Cancer Institute (NCI)
Conditions:
Hereditary Cancer
Genetic Testing
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this observational study is to increase genetic education and genetic testing for hereditary cancer risk among Black cancer survivors. The study will: 1. Test the effectiveness of a chatb...
Detailed Description
Research Design and Methods: This study will employ a 2-arm parallel group randomized controlled trial to evaluate the efficacy of the RA intervention compared to EUC among 428 Black cancer survivors...
Eligibility Criteria
Inclusion
- 18-80 years of age
- Self-identify as Black or African American
- At least 6-months post diagnosis with any of the following cancers: breast, ovarian, uterine, prostate, colorectal, pancreatic
- Have not had genetic testing for hereditary cancer
- Have received care at one of the participating sites in the prior five years
- Meet National Comprehensive Cancer Network criteria for germline GT
- Able to read and speak in English
- Capable of providing informed consent
- Have internet access (via smartphone, tablet or computer)
- Comfortable using a computer or mobile phone independently to access information
Exclusion
- Do not speak English
- Unable to access the Internet
- Have previously undergone germline genetic testing for hereditary cancer risk or previously had genetic counseling (GC) and declined genetic testing (GT)
- Are unable to provide informed consent
Key Trial Info
Start Date :
July 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
428 Patients enrolled
Trial Details
Trial ID
NCT06073626
Start Date
July 31 2024
End Date
August 31 2027
Last Update
October 28 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States, 20007
2
Rutgers Cancer Institute
New Brunswick, New Jersey, United States, 08901